Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|November 19, 2024
Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103Erhad Ascic, Mauro Marigo, Laurent David, et al.Neuron|September 2, 2019
A Rare Mutation of β1-Adrenergic Receptor Affects Sleep/Wake BehaviorsGuangsen Shi, Lijuan Xing, David Wu, et al.ACS Medicinal Chemistry Letters|December 21, 2016
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 InhibitorsWilliam McCoull, Edward J Hennessy, Kevin Blades, et al.Proceedings of the National Academy of Sciences of the United States of America|February 24, 2016
A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood traitLuoying Zhang, Arisa Hirano, Pei-Ken Hsu, et al.Microbial Genomics|February 27, 2026
Nanopore long-read-only genome assembly of clinical Enterobacterales isolates is complete and accurateDorottya Nagy, Valentina Pennetta, Gillian Rodger, et al.Journal of Medical Microbiology|May 21, 2024
The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in EnglandChristopher R Jones, Claire Neill, Andrew M Borman, et al.Open Forum Infectious Diseases|January 23, 2018
Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care ContinuumAlastair Heffernan, Ella Barber, Nicola A Cook, et al.Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of MigraineSarah J Bucknell, Mark A Ator, Alastair J H Brown, et al.Journal of Medicinal Chemistry|May 16, 2015
Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2Richard A Ward, Nicola Colclough, Mairi Challinor, et al.BMJ Health & Care Informatics|November 20, 2020
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis researchDavid Anthony Smith, Tingyan Wang, Oliver Freeman, et al.Pageof 10